Compare · CGC vs USNA
CGC vs USNA
Side-by-side comparison of Canopy Growth Corporation (CGC) and USANA Health Sciences Inc. (USNA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CGC and USNA operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- CGC is the larger of the two at $2.86B, about 7.1x USNA ($402.9M).
- Over the past year, CGC is down 13.2% and USNA is down 28.2% - CGC leads by 15.0 points.
- CGC has been more active in the news (12 items in the past 4 weeks vs 2 for USNA).
- CGC has more recent analyst coverage (19 ratings vs 3 for USNA).
- Company
- Canopy Growth Corporation
- USANA Health Sciences Inc.
- Price
- $0.95+1.40%
- $21.79-3.71%
- Market cap
- $2.86B
- $402.9M
- 1M return
- -0.82%
- +14.44%
- 1Y return
- -13.25%
- -28.23%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 12
- 2
- Recent ratings
- 19
- 3
Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
USANA Health Sciences Inc.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Latest CGC
- SEC Form PRE 14A filed by Canopy Growth Corporation
- Director Bayern Joseph sold $2,953 worth of shares (3,197 units at $0.92), decreasing direct ownership by 2% to 145,127 units (SEC Form 4) (withholding tax)
- Director Yanofsky Theresa sold $13,905 worth of shares (15,054 units at $0.92), decreasing direct ownership by 9% to 146,415 units (SEC Form 4) (withholding obligation)
- Director Atkins M Shan sold $2,953 worth of shares (3,197 units at $0.92), decreasing direct ownership by 2% to 146,517 units (SEC Form 4) to cover taxes
- Director Lazzarato David Angelo sold $20,944 worth of shares (22,674 units at $0.92), decreasing direct ownership by 10% to 211,859 units (SEC Form 4) to cover withholding tax
- Director Atkins M Shan was granted 108,324 shares, increasing direct ownership by 262% to 149,714 units (SEC Form 4)
- Director Lazzarato David Angelo was granted 162,485 shares, increasing direct ownership by 226% to 234,533 units (SEC Form 4)
- Director Bayern Joseph was granted 108,324 shares, increasing direct ownership by 271% to 148,324 units (SEC Form 4)
- Director Yanofsky Theresa was granted 108,324 shares, increasing direct ownership by 204% to 161,469 units (SEC Form 4)
- Officer Stewart Thomas Carlton was granted 379,018 shares and sold $9,045 worth of shares (9,285 units at $0.97), increasing direct ownership by 150% to 616,398 units (SEC Form 4) to satisfy withholding tax
Latest USNA
- USANA Schedules Second Quarter 2026 Earnings Release and Conference Call
- Kevin Guest: World Cup Determination Shows the Power of Grit, Preparation, Persistence
- CHIEF COMMERCIAL OFFICER Neidig Brent sold $97,304 worth of shares (5,002 units at $19.45), closing all direct ownership in the company (SEC Form 4)
- CHIEF COMMERCIAL OFFICER Neidig Brent sold $50,465 worth of shares (2,511 units at $20.10), decreasing direct ownership by 33% to 5,002 units (SEC Form 4)
- USANA Celebrates 10 Years of Making the World a Better Place During World Service Week
- SEC Form 11-K filed by USANA Health Sciences Inc.
- CHIEF PEOPLE OFFICER Jones Paul A. sold $102,878 worth of shares (5,561 units at $18.50), closing all direct ownership in the company (SEC Form 4)
- USANA's Celavive Contouring Face & Neck Crème Named Among Canada's Top Skincare Products
- USANA Earns Dual Best of State Honors for Product Innovation and Development
- Director Fleming John Turman sold $43,928 worth of shares (2,450 units at $17.93), decreasing direct ownership by 37% to 4,230 units (SEC Form 4)